Cost‐effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure

MLA

Robert J.H. Miller, et al. “Cost‐effectiveness of Immediate Initiation of Dapagliflozin in Patients with a History of Heart Failure.” European Journal of Heart Failure, vol. 25, Feb. 2023, pp. 238–47. EBSCOhost, https://doi.org/10.1002/ejhf.2777.

APA

Robert J.H. Miller, Derek S. Chew, Lei Qin, Nowell M. Fine, Jieling Chen, John J.V. McMurray, Jonathan G. Howlett, & Phil McEwan. (2023). Cost‐effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure. European Journal of Heart Failure, 25, 238–247. https://doi.org/10.1002/ejhf.2777

Chicago

Robert J.H. Miller, Derek S. Chew, Lei Qin, Nowell M. Fine, Jieling Chen, John J.V. McMurray, Jonathan G. Howlett, and Phil McEwan. 2023. “Cost‐effectiveness of Immediate Initiation of Dapagliflozin in Patients with a History of Heart Failure.” European Journal of Heart Failure 25 (February): 238–47. doi:10.1002/ejhf.2777.